Clinical Trial Update: Acceptability Study of a New Paediatric Form of Vigabatrin in Infants and Children With Infantile Spasms or Pharmacoresistant Partial Epilepsy [NA]

View source ↗

Summary

Completed acceptability study evaluating a new pediatric formulation of vigabatrin for infants with infantile spasms or drug-resistant focal epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Focal Epilepsy
• Infantile Spasms

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

Sponsor: Orphelia Pharma | Conditions: Infantile Spasms | NA | Status: COMPLETED